This application represents the first competitive renewal for our Training in Emerging Infectious Diseases (EID) T32 program. Of the more than 60 faculty at the University of Pennsylvania whose primary affiliation is with the microbiology program, a select group of 14 well-funded faculty are trainers in this program. All of the trainers have significant research programs in emerging infectious diseases, more than half are funded in part by the Middle Atlantic Regional Center of Excellence (MARCE) in Biodefense and Emerging Infectious Diseases, and all participate in training activities and minority recruitment efforts. During its first 4 years, this T32 provided support for 3 predoctoral and 2 postdoctoral trainees per year who could work in any one of 14 different laboratories directed by investigators who study a variety of emerging and re-emerging pathogens. To date, a total of 14 trainees have been supported by this T32, virtually all for 2 years, including 7 Ph.D. students, 1 M.D./Ph.D. student, 1 VMD/Ph.D. student and 5 Ph.D. postdoctoral fellows. These 14 trainees have worked in the labs of 9 different trainers. Of the 14 current and past trainees, 8 are women, 6 are men, and 2 are minorities. Of the 3 postdoctoral fellows who have completed their training and left Penn, one is an Assistant Professor, one is a staff scientist at the NIH where he studies Ebola virus, and one is in industry developing viral vaccines. Of the 3 students who have left Penn, two are postdoctoral fellows where they continue to study infectious diseases, and one is a scientist in industry. Two additional students who will graduate soon will be undertaking postdoctoral fellowships at USAMRIID and the Special Pathogens Branch of the CDC, respectively. The EID T32 program has served to unite our investigators and trainees, who study many different pathogens, in ways that would not otherwise have occurred. After the T32 was funded, the trainers developed what is now a popular graduate level course on emerging infectious diseases, started a monthly Zoonotic Diseases Seminar series that is attended by our faculty and trainees, and began an initiative in which all of our trainees receive extensive BSL3 training. We have started a Certificate Program in Public Health in response to the fact that so many of our trainees are interested in emerging infectious diseases and global health issues, and this summer launched a 3-week long summer biostatistics course to betaken by our trainees, recognizing that much of the EID literature consists of epidemiological studies coupled with the belief that a stronger background in statistics and quantitative methods will help prepare our trainees for careers in science. We also send our trainees to the regional MARCE meetings, held twice each year, and this in turn has led to new collaborations for our trainees as well as training opportunities. In light of the need to continue to train young scientists to work in emerging infectious diseases, we propose to renew this successful program. Due to the difficult funding climate for T32 grants, we propose to maintain this program at its present size of 3 students and 2 postdocs per year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI055400-08
Application #
7864058
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Peters, Kent
Project Start
2003-08-01
Project End
2013-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
8
Fiscal Year
2010
Total Cost
$172,722
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Otwinowski, Jakub (2018) Biophysical Inference of Epistasis and the Effects of Mutations on Protein Stability and Function. Mol Biol Evol 35:2345-2354
Kudchodkar, Sagar B; Choi, Hyeree; Reuschel, Emma L et al. (2018) Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus. Microbes Infect 20:676-684
Barbian, Hannah J; Connell, Andrew Jesse; Avitto, Alexa N et al. (2018) CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 8:7946-7963
Otwinowski, Jakub; McCandlish, David M; Plotkin, Joshua B (2018) Inferring the shape of global epistasis. Proc Natl Acad Sci U S A 115:E7550-E7558
Wang, Yang; Esquivel, Rianne; Flingai, Seleeke et al. (2018) Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice. J Infect Dis :
Patel, Ami; Park, Daniel H; Davis, Carl W et al. (2018) In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model. Cell Rep 25:1982-1993.e4
Barbian, Hannah J; Li, Yingying; Ramirez, Miguel et al. (2018) Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol 80:
Casson, Cierra N; Doerner, Jessica L; Copenhaver, Alan M et al. (2017) Neutrophils and Ly6Chi monocytes collaborate in generating an optimal cytokine response that protects against pulmonary Legionella pneumophila infection. PLoS Pathog 13:e1006309
Barbian, Hannah J; Jackson-Jewett, Raven; Brown, Corrine S et al. (2017) Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee. Retrovirology 14:35
Zhou, Wei; Brisson, Dustin (2017) Correlation between antigenicity and variability in the vls antigenic variation system of Borrelia burgdorferi. Microbes Infect 19:267-276

Showing the most recent 10 out of 72 publications